Finding could have implications for other autoimmune disorders, such as type I diabetes
Scientists from the Gladstone Institutes have discovered a way to prevent the development of multiple sclerosis (MS) in mice. Using a drug that blocks the production of a certain type of immune cell linked to inflammation and autoimmunity, the researchers successfully protected against the onset of MS in an animal model of the disease. The scientists say the next step is to test this strategy using other autoimmune disorders.
“We are very excited about these findings,” says Eric Verdin, MD, a senior investigator at Gladstone and co-senior author on the study. “In light of the significant effect the treatment had on inflammation, the implications of these results will likely extend beyond multiple sclerosis to other types of autoimmune disorders. We are particularly interested in testing this in type I diabetes given the similar pathways involved, and we are already seeing very promising results in preliminary experiments.”
In the immune system, two kinds of T cells strike a delicate balance–T helper cells (Th17) activate the immune system, protecting against infections and cancers, while regulatory T cells (Tregs) suppress the system, keeping it in check. A disparity between these cell types, where there are too many Th17 and not enough Tregs, can lead to a hyperactive immune system, resulting in inflammation, tissue damage, and autoimmune disease.
In the current study, published in the Journal of Experimental Medicine, the researchers discovered that an important regulatory protein, sirtuin 1 (SIRT1), is involved in the production of Th17 cells. By blocking this protein, the scientists can protect against the onset of autoimmunity. SIRT1 also has a negative impact on Treg maturation and maintenance, so inhibiting its expression simultaneously enhances the production of Tregs and suppresses the creation of Th17.
To test this effect on disease, the researchers used a mouse model of MS and treated the animals with a drug that inhibits SIRT1. Typically, MS-model mice experience severe motor problems, eventually leading to paralysis, but when they were given the drug the mice behaved perfectly normally. Moreover, the treated animals showed no signs of inflammation or cell damage in their spines, classic markers for MS.
The Latest on: Inflammation and autoimmunity
via Google News
The Latest on: Inflammation and autoimmunity
- Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammationon January 10, 2020 at 5:16 am
Psoriasis is an autoimmune skin disease, where chronic immune responses due to exaggerated ... From the therapeutic perspective, the molecules with strong anti-proliferative and anti-inflammatory ...
- HMP Announces Launch of Autoimmune Learning Networkon January 10, 2020 at 5:00 am
The Autoimmune Learning Network serves as a robust digital hub of information and education focused on care innovations for patients with immune-mediated inflammatory diseases (IMIDs). Designed for a ...
- Anokion to Participate in Autoimmune and Inflammatory Disease Panel at 2020 Biotech Showcaseon January 8, 2020 at 4:30 am
Hohneker, M.D., president and chief executive officer of Anokion, will participate in an expert panel titled, “Autoimmune and Inflammatory Disease (AIID): Beyond the sledgehammer approach,” on January ...
- New medicine can revolutionize treatment of inflammatory diseases and canceron January 7, 2020 at 8:34 pm
In high concentrations, however, ROS damage tissue, cause uncontrolled inflammation and are involved in triggering cancer and autoimmune diseases. Paradoxically, however, amplifying oxygen radicals ...
- Immunotherapy Drugs Market Size 2020 (Value and Volume), Future Potential of Forecast To 2025on January 7, 2020 at 7:06 am
New York, January 07, 2020: The Immunotherapy Drugs Marketon geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each ...
- Study Shows HK L-137 Reduces Inflammation in Healthy Overweight Individuals — Takes Front Line Against Metabolic Syndromeon January 7, 2020 at 3:45 am
Many have gone as far as to suggest that inflammation is the defining characteristic of all infirmity, including the depredating aspects of the aging process itself, leading to eventual organ failure.
- Bile acids could also play a role in immunity and inflammationon January 3, 2020 at 7:59 pm
The work suggests possible therapeutic pathways for modulating intestinal inflammation, a process that underlies the development of autoimmune conditions such as inflammatory bowel disease, commonly ...
- Fat-dissolving bile acids may help regulate gut immunity and inflammationon January 3, 2020 at 9:22 am
The work suggests possible therapeutic pathways for modulating intestinal inflammation, a process that underlies the development of autoimmune conditions such as inflammatory bowel disease ...
- Know thy mitochondria: Autoimmunity to organelles and their DNAon January 3, 2020 at 8:03 am
Reactive oxygen species (ROS), immunogenic mitochondrial DNA (mtDNA), and even whole mitochondria are locally mobilized in a delicate balance to create hot spots of inflammatory action. When normal ...
- NIH grant supports study of early-life adversity and lifetime disease riskon January 2, 2020 at 8:09 am
“My lab has studied this phenomenon using pigs and other animal models, we believe hyperactive mast cells are central players in chronic lifelong inflammation induced by early-life stress, which is ...
via Bing News